Are Indoleamine-2,3-Dioxygenase Producing Human Dendritic Cells a Tool for Suppression of Allogeneic T-cell Responses?

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Transplantation

• Publication date

  2007-02-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/01.tp.0000251646.09702.ecPMID 17318080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of Indoleamine 2,3‐Dioxygenase (IDO) by Endothelial Cells: Implications for the Control of Alloresponses

  2006cited by this paper
• The immunoregulatory role of IDO-producing human dendritic cells revisited.

  2006cited by this paper
• Function of indoleamine 2,3‐dioxygenase in corneal allograft rejection and prolongation of allograft survival by over‐expression

  2006cited by this paper
• Dendritic cells have the option to express IDO-mediated suppression or not.

  2005cited by this paper
• Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?

  2005cited by this paper
• Dendritic Cells: Tools and Targets for Transplant Tolerance

  2005cited by this paper
• Tolerogenic dendritic cells.

  2003cited by this paper
• Proliferation of peripheral blood mononuclear cells is suppressed by the indoleamine 2,3‐dioxygenase expression of interferon‐γ–treated skin cells in a co‐culture system

  2003cited by this paper
• A Novel Role for IL-3: Human Monocytes Cultured in the Presence of IL-3 and IL-4 Differentiate into Dendritic Cells That Produce Less IL-12 and Shift Th Cell Responses Toward a Th2 Cytokine Pattern1

  2002cited by this paper
• Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes.

  2002cited by this paper
• Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells

  2002cited by this paper
• Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase

  2002influential reference
• Potential of tolerogenic dendritic cells for transplantation.

  2001cited by this paper
• Characterisation of L‐tryptophan transporters in human placenta: a comparison of brush border and basal membrane vesicles

  2001cited by this paper
• Inhibition of  T Cell Proliferation by Macrophage Tryptophan Catabolism

  1999cited by this paper
• Prevention of allogeneic fetal rejection by tryptophan catabolism.

  1998cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• Simultaneous measurement of serum tryptophan and kynurenine by HPLC.

  1997cited by this paper
• Induction of tolerance by IL-10-treated dendritic cells.

  1997influential reference
• Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.

  1997cited by this paper
• Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.

  1996cited by this paper
• Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells

  1982cited by this paper

• miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer

  2019cites this paper
• Development of a Scalable Synthesis of BMS-978587 Featuring a Stereospecific Suzuki Coupling of a Cyclopropane Carboxylic Acid

  2018cites this paper
• Dysregulated expression of IDO may cause unexplained recurrent spontaneous abortion through suppression of trophoblast cell proliferation and migration

  2016cites this paper
• Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues

  2014cites this paper
• pathway for premature atherosclerosis promotes abnormal vasculogenesis in lupus: a potential α Interferon-

  2013cites this paper
• Developmental and cholera toxin-induced alterations in the expression of intracellular signalling molecules

  2013cites this paper
• The ratio between dendritic cells and T cells determines whether prostaglandin E2 has a stimulatory or inhibitory effect.

  2013cites this paper
• Indoleamine 2,3‐dioxygenase Expression and Functional Activity in Dendritic Cells Exposed to Cholera Toxin

  2012cites this paper
• IDO and Regulatory T Cell Support Are Critical for Cytotoxic T Lymphocyte-Associated Ag-4 Ig-Mediated Long-Term Solid Organ Allograft Survival

  2012cites this paper
• IDO1 (indoleamine 2,3-dioxygenase 1)

  2011cites this paper
• Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?

  2009cites this paper
• Indoleamine 2,3-dioxygenase in lung allograft tolerance.

  2009cites this paper
• Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells.

  2009cites this paper
• Role of IDO in Organ Transplantation: Promises and Difficulties

  2009cites this paper
• Dendritic cells in cancer

  2009cites this paper
• Role of IDO in Dendritic Cell Differentiation and Function in Cancer

  2009cites this paper
• The role of T-regulatory cells in pregnancy and cancer.

  2008cites this paper
• IDO-expressing regulatory dendritic cells in cancer and chronic infection

  2008cites this paper
• Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction?

  2008cites this paper
• Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells.

  2008cites this paper
• Indoleamine 2,3‐dioxygenase in transplantation (Review Article)

  2008cites this paper
• Interferon- (cid:1) promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis

  2007cites this paper
• Tolerance Signaling Molecules and Pregnancy: IDO, Galectins, and the Renaissance of Regulatory T Cells

  2007cites this paper
• Interferon-α promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis

  2007cites this paper